Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line

OBJECTIVES: The objectives of this study were to 1) describe and compare treatment persistence with first- and second-line subcutaneous tumor necrosis factor-alpha inhibitors (SC-TNFis) in patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA), or rheumatoid arthritis (RA) (collectivel...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Patient Prefer Adherence
Hoofdauteurs: Svedbom, Axel, Dalén, Johan, Black, Christopher M, Kachroo, Sumesh
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2017
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248937/
https://ncbi.nlm.nih.gov/pubmed/28144130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S119808
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items